E-cadherin levels are inversely proportional to disease progression; metastatic NPC tumors display lower E-cadherion mRNA and protein levels than primary NPC tumors (19% in primary tumors vs. 42% in metastatic tumors) [86]. Here, CDH1 is linked to nasopharyngeal carcinoma.